{"id":11727,"date":"2007-11-22T10:30:00","date_gmt":"2007-11-22T09:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/glaxo-con-reliant-crescera-nel-settore-cardiovascolare\/"},"modified":"2007-11-22T10:30:00","modified_gmt":"2007-11-22T09:30:00","slug":"glaxo-con-reliant-crescera-nel-settore-cardiovascolare","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/glaxo-con-reliant-crescera-nel-settore-cardiovascolare\/","title":{"rendered":"GLAXO: WITH RELIANT YOU WILL GROW IN THE CARDIOVASCULAR SECTOR"},"content":{"rendered":"<p>&nbsp;<br \/> GlaxoSmithKline to acquire Reliant for \u20ac1.1 billion in cash. With the operation, Glaxo acquires the cardiological specialty Lovaza, which allows it to strengthen its presence in the USA in this segment. Sales of cardiovascular specialties accounted for approximately \u00a31.64 billion (of the total \u00a320 billion) of Glaxo&#039;s turnover last year. Reliant reported sales of 341 million in the first nine months of 2007 and should contribute to Glaxo&#039;s profits as early as 2008. Finanza e Mercati dated 22\/11\/2007 p. 12&nbsp;&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp; GlaxoSmithKline rilever&agrave; Reliant per 1,1 miliardi di euro cash. Con l&#8217;operazione, Glaxo acquisisce la specialit&agrave; cardiologica Lovaza, che le consente di rafforzare la sua presenza in Usa proprio in questo segmento. L&#8217;anno scorso le vendite di specialit&agrave; cardiovascolari hanno pesato per circa 1,64 miliardi di sterline (dei 20 miliardi totali) sul fatturato di Glaxo. &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-11727","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/11727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=11727"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/11727\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=11727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=11727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=11727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}